Search
EVT 302
go.drugbank.com/drugs/DB06057InvestigationalIt is in the development for smoking cessation, and potential for disease modification in Alzheimer's disease.
OTL-102
go.drugbank.com/drugs/DB18642ExperimentalIt is being investigated for the treatment of X-linked chronic granulomatous disease. … OTL-102 consists of autologous CD34+ enriched cells that contain hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene.
Synonyms: Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox geneBaicalein
go.drugbank.com/drugs/DB16101Investigationalin the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever). … Baicalein is under investigation in clinical trial NCT03830684 (A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase ⅡA Clinical Trial for the Effectiveness and Safety of Baicalein Tablets
Ebaresdax
go.drugbank.com/drugs/DB21496InvestigationalEbaresdax is under investigation in clinical trial NCT05008835 (Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee).
Defoslimod
go.drugbank.com/drugs/DB20763InvestigationalThe usage of the INN stem '-imod' in the name indicates that Defoslimod is a immunomodulator, both stimulant/suppressive and stimulant.
Empesertib
go.drugbank.com/drugs/DB19473InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Empesertib is a serine/threonine kinase inhibitor.
Ancremonam
go.drugbank.com/drugs/DB19710InvestigationalThe usage of the INN stem '-monam' in the name indicates that Ancremonam is a monobactam antibiotic.
Mevociclib
go.drugbank.com/drugs/DB21454InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Mevociclib is a cyclin dependant kinase inhibitor.
Risvodetinib
go.drugbank.com/drugs/DB21602InvestigationalThe usage of the INN stem '-tinib' in the name indicates that Risvodetinib is a tyrosine kinase inhibitor.
LX6171
go.drugbank.com/drugs/DB05180InvestigationalLX6171 is an oral drug candidate that was generated by Lexicon medicinal chemists and is being developed to treat disorders characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia